» Articles » PMID: 36680229

Sensibility and Specificity of the VitaPCR™ SARS-CoV-2 Assay for the Rapid Diagnosis of COVID-19 in Older Adults in the Emergency Department

Abstract

(1) Background: During the COVID-19 pandemic, rapid and reliable diagnostic tools are needed for detecting SARS-CoV-2 infection in urgent cases at admission to the hospital. We aimed to assess the performances of the rapid molecular VitaPCR™ test (Menarini Diagnostics) in a sample of older adults admitted to the Emergency Department of two Italian hospitals (2) Methods: The comparison between the rapid VitaPCR™ and the RT-PCR was performed in 1695 samples. Two naso-pharyngeal swab samplings from each individual were obtained and processed using the VitaPCR™ and the RT-PCR for the detection of SARS-CoV-2 (3) Results: VitaPCR™ exhibited good precision (<3% CV) and an almost perfect overall agreement (Cohen’s K = 0.90) with the RT-PCR. The limit of detection of the VitaPCR™ was 4.1 copies/µL. Compared to the RT-PCR, the sensitivity, the specificity, and the positive and negative predictive values of VitaPCR™ were 83.4%, 99.9%, 99.2% and 98.3%, respectively (4) Conclusions: The VitaPCR™ showed similar sensitivity and specificity to other molecular-based rapid tests. This study suggests that the VitaPCR™ can allow the rapid management of patients within the Emergency Department. Nevertheless, it is advisable to obtain a negative result by a RT-PCR assay before admitting a patient to a regular ward.

References
1.
Trombley Hall A, McKay Zovanyi A, Christensen D, Koehler J, Devins Minogue T . Evaluation of inhibitor-resistant real-time PCR methods for diagnostics in clinical and environmental samples. PLoS One. 2013; 8(9):e73845. PMC: 3767612. DOI: 10.1371/journal.pone.0073845. View

2.
Wolters F, van de Bovenkamp J, van den Bosch B, van den Brink S, Broeders M, Chung N . Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic. J Clin Virol. 2020; 128:104426. PMC: 7211760. DOI: 10.1016/j.jcv.2020.104426. View

3.
Lee S, Kim T, Lee E, Lee C, Kim H, Rhee H . Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea. JAMA Intern Med. 2020; 180(11):1447-1452. PMC: 7411944. DOI: 10.1001/jamainternmed.2020.3862. View

4.
Tu Y, Iqbal J, OLeary T . Sensitivity of ID NOW and RT-PCR for detection of SARS-CoV-2 in an ambulatory population. Elife. 2021; 10. PMC: 8081522. DOI: 10.7554/eLife.65726. View

5.
Ricco M, Ferraro P, Gualerzi G, Ranzieri S, Henry B, Said Y . Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data. J Clin Med. 2020; 9(5). PMC: 7290955. DOI: 10.3390/jcm9051515. View